Table 4

TTE findings for SARS-CoV-2 positive patients

CharacteristicAll (n=27)Died (n=7)Survived (n=20)P value
Left ventricular ejection fraction, N (%)
 >55%22 (81.5)6 (85.7)16 (80.0)1.00
 45%–55%000
 35%–44%2 (7.4)02 (10.0)
 <35%000
 Not documented3 (11.1)1 (14.3)2 (10.0)
Left ventricular size and contractility, N (%)
 Normal size21 (77.8)7 (100.0)14 (70.0)0.44
 Left ventricular hypertrophy2 (7.4)02 (10.0)
 Left ventricular dilation000
 Regional wall motion abnormalities4 (14.8)04 (20.0)
Right ventricular size and function, N (%)
 Normal size and function22 (81.5)7 (100.0)15 (75.0)0.66
 Normal size, impaired function000
 Dilated, normal function1 (3.7)01 (5.0)
 Dilated, impaired function4 (14.8)04 (20.0)
Other findings, N (%)
 Pericardial effusion >1 cm0001.00
 Pericardial effusion <1 cm1 (3.7)01 (5.0)
 Valve disease2 (7.4)02 (10.0)1.00
  • TTE, transthoracic echocardiography.